type: exampleresource: PlanDefinitionexample: plandefinition-example-kdn5-simplified
PlanDefinition Example: plandefinition-example-kdn5-simplified
Narrative
| National Comprehensive Cancer Network
| | --- |
Example XML
<?xml version="1.0" encoding="UTF-8"?>
<PlanDefinition xmlns="http://hl7.org/fhir">
<id value="KDN5"/>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">
<table style="width: 100%;">
<tr>
<td>
<div style="width: 200px; height: 100px; vertical-align: top;">National Comprehensive Cancer Network</div>
</td>
<td>
<h3>Chemotherapy Order Template</h3>
<h1>Kidney Cancer</h1>
<h2>Gemcitabine/CARBOplatin</h2>
</td>
<td style="text-align: right; vertical-align: top;">KDN5</td>
</tr>
</table>
<table style="width: 100%; border-top: 1px solid; border-bottom: 1px solid;">
<tr>
<td style="width: 33%; border-right: 1px solid; vertical-align: top">
<h4>INDICATION:</h4>
<p>Metastatic or Relapsed – Collecting Duct/Medullary Subtypes</p>
</td>
<td style="width: 34%; border-right: 1px solid; vertical-align: top">
<h4>REFERENCES:</h4>
<ol>
<li>
<a href="http://www.example.org/professionals/physician_gls/PDF/kidney.pdf">NCCN Guidelines® for Kidney Cancer. V.3.2015.</a>
</li>
<li>
<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22The+Journal+of+urology%22%5BJour%5D+AND+1698%5Bpage%5D+AND+2007%5Bpdat%5D+AND+Oudard+S%5Bauthor%5D">Oudard S, et al.
<em>J Urol</em>. 2007;177(5):1698-702.
</a>
<sup>
<a href="http://www.example.org/OrderTemplates/PDF/appendix_E.pdf">a</a>
</sup>
</li>
</ol>
</td>
<td style="width: 33%; vertical-align: top">
<h4>NCCN SUPPORTIVE CARE:</h4>
<ol>
<li>
<i>Emetic Risk:</i>
<table>
<tr>
<td>Day 1</td>
<td>Moderate</td>
</tr>
<tr>
<td>Day 8</td>
<td>Low</td>
</tr>
</table>
</li>
<li>
<i>Fever Neutropenia Risk:</i>
<br/>
Refer to
<a href="http://www.example.org/professionals/physician_gls/PDF/myeloid_growth.pdf">NCCN Guidelines for Myeloid Growth Factors. V.2.2014</a>
</li>
</ol>
</td>
</tr>
</table>
<h4>CHEMOTHERAPY REGIMEN</h4>
<p>
<i>21-day cycle for 6 cycles</i>
</p>
<ul>
<li>Gemcitabine 1250 mg/m
<sup>2</sup> IV over 30 minutes on Days 1 and 8
</li>
<li>CARBOplatin AUC 5 IV over 30 minutes on Day 1</li>
</ul>
</div>
</text>
<contained>
<ActivityDefinition>
<id value="1111"/>
<status value="draft"/>
<productCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="12574"/>
<display value="gemcitabine"/>
</coding>
<text value="gemcitabine"/>
</productCodeableConcept>
<dosage>
<text value="1250 mg/m² IV over 30 minutes"/>
<timing>
<repeat>
<duration value="30"/>
<durationUnit value="min"/>
</repeat>
</timing>
<route>
<text value="IV"/>
</route>
<doseAndRate>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/>
<code value="ordered"/>
<display value="Ordered"/>
</coding>
</type>
<doseQuantity>
<value value="1250"/>
<unit value="mg/m²"/>
</doseQuantity>
</doseAndRate>
</dosage>
</ActivityDefinition>
</contained>
<contained>
<ActivityDefinition>
<id value="2222"/>
<status value="draft"/>
<productCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="40048"/>
<display value="Carboplatin"/>
</coding>
<text value="CARBOplatin"/>
</productCodeableConcept>
<dosage>
<text value="AUC 5 IV over 30 minutes"/>
<timing>
<repeat>
<duration value="30"/>
<durationUnit value="min"/>
</repeat>
</timing>
<route>
<text value="IV"/>
</route>
<doseAndRate>
<type>
<coding>
<system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/>
<code value="ordered"/>
<display value="Ordered"/>
</coding>
</type>
<doseQuantity>
<extension url="http://example.org/fhir/AUC-dose">
<valueInteger value="5"/>
</extension>
</doseQuantity>
</doseAndRate>
</dosage>
</ActivityDefinition>
</contained>
<identifier>
<system value="http://example.org/ordertemplates"/>
<value value="KDN5"/>
</identifier>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:oid:2.16.840.1.113883.4.642.11.21"/>
</identifier>
<version value="1"/>
<name value="GemcitabineCARBOplatin"/>
<title value="Gemcitabine/CARBOplatin"/>
<type>
<text value="Chemotherapy Order Template"/>
</type>
<status value="draft"/>
<experimental value="true"/>
<publisher value="National Comprehensive Cancer Network, Inc."/>
<description value="Gemcitabine/CARBOplatin"/>
<useContext>
<code>
<system value="http://example.org/fhir/CodeSystem/indications"/>
<code value="treamentSetting-or-diseaseStatus"/>
</code>
<valueCodeableConcept>
<text value="Metastatic"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system value="http://example.org/fhir/CodeSystem/indications"/>
<code value="disease-or-histology"/>
</code>
<valueCodeableConcept>
<text value="Collecting Duct/Medullary Subtypes"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<text value="Kidney Cancer"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system value="http://example.org/fhir/CodeSystem/indications"/>
<code value="treatmentSetting-or-diseaseStatus"/>
</code>
<valueCodeableConcept>
<text value="Relapsed"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system value="http://example.org/fhir/CodeSystem/indications"/>
<code value="disease-or-histology"/>
</code>
<valueCodeableConcept>
<text value="Collecting Duct/Medullary Subtypes"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<text value="Kidney Cancer – Collecting Duct/Medullary Subtypes - Metastatic"/>
</valueCodeableConcept>
</useContext>
<copyright value="All rights reserved."/>
<approvalDate value="2016-07-27"/>
<lastReviewDate value="2016-07-27"/>
<author>
<name value="Lee Surprenant"/>
</author>
<relatedArtifact>
<type value="derived-from"/>
<display value="NCCN Guidelines for Kidney Cancer. V.2.2016"/>
<document>
<url value="http://www.example.org/professionals/physician_gls/PDF/kidney.pdf"/>
</document>
</relatedArtifact>
<relatedArtifact>
<type value="citation">
<extension url="http://example.org/fhir/regimenReferenceType">
<valueCode value="a"/>
</extension>
</type>
<citation value="Oudard S, et al. J Urol. 2007;177(5):1698-702"/>
<document>
<url value="http://www.ncbi.nlm.nih.gov/pubmed/17437788"/>
</document>
</relatedArtifact>
<action>
<selectionBehavior value="exactly-one"/>
<action>
<selectionBehavior value="all"/>
<action>
<groupingBehavior value="sentence-group"/>
<selectionBehavior value="exactly-one"/>
<action id="cycle-definition-1">
<textEquivalent value="21-day cycle for 6 cycles"/>
<timingTiming>
<repeat>
<count value="6"/>
<duration value="21"/>
<durationUnit value="d"/>
</repeat>
</timingTiming>
<action id="action-1">
<extension url="http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle">
<extension url="day">
<valueInteger value="1"/>
</extension>
<extension url="day">
<valueInteger value="8"/>
</extension>
</extension>
<textEquivalent value="Gemcitabine 1250 mg/m² IV over 30 minutes on days 1 and 8"/>
<definitionCanonical value="#1111"/>
</action>
<action id="action-2">
<extension url="http://hl7.org/fhir/StructureDefinition/timing-daysOfCycle">
<extension url="day">
<valueInteger value="1"/>
</extension>
</extension>
<textEquivalent value="CARBOplatin AUC 5 IV over 30 minutes on Day 1"/>
<relatedAction>
<targetId value="action-1"/>
<relationship value="concurrent-with-start"/>
</relatedAction>
<definitionCanonical value="#2222"/>
</action>
</action>
</action>
</action>
</action>
</PlanDefinition>